terazosin and Apoplexy studies

terazosin and Apoplexy

terazosin has been researched along with Apoplexy in 2 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Research Excerpts

Excerpt	Relevance	Reference
"Treatment of benign prostatic hyperplasia (BPH) with nonselective alpha1 antagonists such as terazosin, doxazosin, and prazosin results in blood pressure reduction due to vasodilation."	3.71	Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. ( Chao, J; Chrischilles, E; Gilden, D; Kreder, KJ; Rubenstein, L; Shah, H, 2001)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Chen, X	1
Zhao, C	1
Li, X	2
Wang, T	1
Li, Y	1
Cao, C	1
Ding, Y	1
Dong, M	1
Finci, L	1
Wang, JH	1
Liu, L	1
Chrischilles, E	1
Rubenstein, L	1
Chao, J	1
Kreder, KJ	1
Gilden, D	1
Shah, H	1

Studies

Chen, X

Zhao, C

Li, X

Wang, T

Li, Y

Cao, C

Ding, Y

Dong, M

Finci, L

Wang, JH

Liu, L

Chrischilles, E

Rubenstein, L

Chao, J

Kreder, KJ

Gilden, D

Shah, H

Clinical Trials (2)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Assessing Target Engagement of Terazosin in Healthy Adults[NCT04551040]	Phase 1	18 participants (Anticipated)	Interventional	2021-03-26	Active, not recruiting
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596]	Phase 4	63 participants (Actual)	Interventional	2015-10-29	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Assessing Target Engagement of Terazosin in Healthy Adults[NCT04551040]

Phase 1

18 participants (Anticipated)

Interventional

2021-03-26

Active, not recruiting

The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596]

Phase 4

63 participants (Actual)

Interventional

2015-10-29

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for terazosin and Apoplexy

Article	Year
Terazosin activates Pgk1 and Hsp90 to promote stress resistance. Nature chemical biology, 2015, Volume: 11, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Cells, Cultured; Cytokines; HSP90 Heat-	2015
Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. Clinical therapeutics, 2001, Volume: 23, Issue:5 Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor	2001

Article

Year

Terazosin activates Pgk1 and Hsp90 to promote stress resistance.

Nature chemical biology, 2015, Volume: 11, Issue:1

Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Cells, Cultured; Cytokines; HSP90 Heat-

2015

Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.

Clinical therapeutics, 2001, Volume: 23, Issue:5

Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor

2001